| 30.06.2022 ARCH Venture raises new $3bn fund to back biotech startups |
| Laxman Pai, Opalesque Asia: Amid a downturn in biotech investments, Chicago, IL-based venture capital firm ARCH Venture Partners raised $2.975 billion to invest in biotech startups. The 12th flagship fund, ARCH Venture Fund XII, is the largest to date for the 35-year-old, which provides seed / early-stage venture capital for technology firms in information technology, life sciences, and ph |
| Article source: https://www.prnewswire.com/news-releases/arch-venture-partners-announces-2-975-billion-fund-xii-to-create-and-fund-early-stage-biotechnology-companies-301577375.html - Opalesque is not responsible for the content of external internet sites |